Our mission is to improve the success of surgeries by enabling surgeons better to distinguish different tissue types and identify malignant lesions. Our proprietary technology enables multiparametric endoscopy where various structural and functional images are provided simultaneously.

The first application of our real-time multispectral imaging technology is in transurethral resections of bladder tumor (TURBT), where we expect it will contribute to reducing disease recurrence and minimizing collateral tissue damage.

THE CURE

rMSI  technology offers the ability to differentiate optically and intuitively whether tissue is malignant or healthy. Surgeons may thus for the first time be able to greatly improve the success rate of operation, improve post-surgery prognosis and in the long term increase the average life expectancy.

Read more…